APIRx Pharmaceutical USA, LLC
USPTO PatentsView assignee record - 7 granted patents across 7 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Apirx ranks #34,267 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 7 technology areas.
- #34,267
- of 49,997 US assignees by volume
- 25th percentile
- by Innovation Score (27.8/100)
- 13.3
- avg claims per patent
USPTO PatentsView assignee plate
Corpus R34267 · US Corporation #34,267 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
- GRANTS-MICRO 7 grants
- MID-PACK #34,267/49,997
- PHOTO-FINISH Aobiome
- CPC-NARROW A61K · 7 areas
- INNOV-THIN 27.8/100
- CLAIMS-RICH 13.3 claims/avg
- TYPE-USCORP US Corporation
- SPAN-YRS 2020–2025 · 6y
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: Aobiome LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Apirx’s 27.8 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Apirx
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Imagination Broadway · near 28
Imagination Broadway · near
28 score
- OnKure · near 28
OnKure · near
28 score
- APIRx Pharmaceutical… · this assignee 28
APIRx Pharmaceutical… · this assignee
28 score
- Thales DIS USA · near 28
Thales DIS USA · near
28 score
- Vudu · near 28
Vudu · near
28 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Apirx's Innovation Score is 27.8/100 (25th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Apirx?
Each dot is one of Apirx’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Apirx’s own 13.3 claims/patent is at or below the 14.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Apirx's grants concentrate
APIRx Pharmaceutical USA, LLC is a focused PatentsView assignee: 7 CPC subclasses with 85.7% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2020. By volume, Apirx sits between Aobiome LLC and Applica SP. Z O.O..
Apirx's three-year grant acceleration
APIRx Pharmaceutical USA, LLC shows 2 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at APIRx's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Aobiome
Aobiome LLC
7 patents
- AOP Orphan Pharma…
AOP Orphan Pharmaceuticals AG
7 patents
- APB
APB Corporation
7 patents
- Aperture Medical…
Aperture Medical Technology LLC
7 patents
- APL Technology AS
APL Technology AS
7 patents
- Apollo Precision…
Apollo Precision Kunming Yuanhong Limited
7 patents
- APOS—Medical and…
APOS—Medical and Sports Technologies Ltd.
7 patents
- Applica SP Z O O
Applica SP. Z O.O.
7 patents
- Apirx Pharmaceuti… ◀
APIRx Pharmaceutical USA, LLC
7 patents
What this shows APIRx holds 7 patents at rank #34,161, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near APIRx
By rank, the assignees closest to #34,161 in granted patent volume.
- Aobiome LLC #34,157 · 7 patents
- AOP Orphan Pharmaceuticals AG #34,158 · 7 patents
- APB Corporation #34,159 · 7 patents
- Aperture Medical Technology LLC #34,160 · 7 patents
- APL Technology AS #34,162 · 7 patents
- Apollo Precision Kunming Yuanhong Limited #34,163 · 7 patents
- APOS—Medical and Sports Technologies Ltd. #34,164 · 7 patents
- Applica SP. Z O.O. #34,165 · 7 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in APIRx's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for APIRx, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), APIRx ranks #3,449 of 7,163 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (28 here).
Apirx's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
28 25th percentile higher than 25% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 1 | 14.3% |
| 2021 | 3 | 42.9% |
| 2022 | 1 | 14.3% |
| 2024 | 1 | 14.3% |
| 2025partial year | 1 | 14.3% |
Which technologies does APIRx Pharmaceutical USA, LLC patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
APIRx Pharmaceutical USA, LLC's patent record in context - here's where to go next.
- APIRx Pharmaceutical USA, LLC's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 85.7% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #34,267 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare APIRx Pharmaceutical USA, LLC against Aobiome LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 27.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.